Nephrocare Health Services to attend IIFL investor conference on February 24

Nephrocare Health Services Limited has announced its participation in the IIFL Conference on February 24, 2026, in Mumbai, where it will engage with analysts and institutional investors through group and one-on-one meetings, in line with regulatory norms.

Nephrocare Health Services Limited has informed stock exchanges about its upcoming participation in the IIFL Conference scheduled for February 24, 2026, in Mumbai. The company will hold group interactions as well as one-on-one meetings with analysts and institutional investors starting from 1:00 PM onwards.

The disclosure was made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was signed by Company Secretary and Compliance Officer Kishore Kathri on February 18, 2026.

Nephrocare clarified that all discussions during the conference will be strictly limited to publicly available information, with no unpublished price sensitive information (UPSI) being shared, ensuring full regulatory compliance.

The company, which is listed on BSE under scrip code 544647 and on NSE under the symbol NEPHROPLUS, also noted that the meeting schedule may be subject to change due to unforeseen circumstances. Details of the disclosure are available on the company’s official website.